Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
Ogawa K, Kanzaki H, Chiba T, Ao J, Qiang N, Ma Y, Zhang J, Yumita S, Ishino T, Unozawa H, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Fujita N, Sakuma T, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Ogasawara S, Suzuki E, Nakamoto S, Muroyama R, Kanda T, Maruyama H, Mimura N, Kato J, Motohashi S, Kato N. Ogawa K, et al. Among authors: nakagawa m, nakagawa r. J Cancer. 2022 May 16;13(8):2656-2661. doi: 10.7150/jca.71494. eCollection 2022. J Cancer. 2022. PMID: 35711837 Free PMC article.
[Development status of DAA against hepatitis C].
Kato N, Nakagawa R, Goto K, Muroyama R, Matsubara Y. Kato N, et al. Among authors: nakagawa r. Nihon Rinsho. 2015 Dec;73 Suppl 9:262-8. Nihon Rinsho. 2015. PMID: 26845942 Japanese. No abstract available.
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T, Kanzaki H, Chiba T, Ao J, Kanayama K, Maruta S, Kusakabe Y, Saito T, Kobayashi K, Kiyono S, Nakamura M, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Nakagawa R, Muroyama R, Kanda T, Maruyama H, Kato N. Maeda T, et al. Among authors: nakagawa r. BMC Cancer. 2019 Nov 12;19(1):1088. doi: 10.1186/s12885-019-6322-9. BMC Cancer. 2019. PMID: 31718608 Free PMC article.
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
Arai J, Goto K, Otoyama Y, Nakajima Y, Sugiura I, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Nakagawa R, Muroyama R, Kato N, Yoshida H. Arai J, et al. Among authors: nakagawa r. Cancer Immunol Immunother. 2021 Jan;70(1):203-213. doi: 10.1007/s00262-020-02660-2. Epub 2020 Jul 18. Cancer Immunol Immunother. 2021. PMID: 32683508 Free PMC article.
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer.
Imai Y, Chiba T, Kondo T, Kanzaki H, Kanayama K, Ao J, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Suzuki E, Nakamoto S, Muroyama R, Tawada A, Matsumura T, Nakagawa T, Kato J, Kotani A, Matsubara H, Kato N. Imai Y, et al. Among authors: nakagawa r, nakagawa t. Oncol Lett. 2020 Sep;20(3):2161-2168. doi: 10.3892/ol.2020.11757. Epub 2020 Jun 19. Oncol Lett. 2020. PMID: 32782533 Free PMC article.
586 results